Showing results (31-40 of 51) with videos related to
Sort By:
Pageof 6
Neurology|December 21, 2012
Mutation of the PDGFRB gene as a cause of idiopathic basal ganglia calcificationGaël Nicolas, Cyril Pottier, David Maltête, et al.Cell|July 1, 2008
A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimer's disease riskUte Dreses-Werringloer, Jean-Charles Lambert, Valérie Vingtdeux, et al.Clinical Chemistry|July 12, 2019
A Simple, Universal, and Cost-Efficient Digital PCR Method for the Targeted Analysis of Copy Number VariationsKévin Cassinari, Olivier Quenez, Géraldine Joly-Hélas, et al.Alzheimer'S Research & Therapy|May 7, 2025
Soluble SorLA in CSF, a novel biomarker to explore disrupted trafficking of SorLA protein in Alzheimer diseaseRomain Castelot, Aline Zarea, David Wallon, et al.Journal of Alzheimer'S Disease : JAD|November 19, 2016
APP Mutations in Cerebral Amyloid Angiopathy with or without Cortical Calcifications: Report of Three Families and a Literature ReviewFrançois Sellal, David Wallon, Laurent Martinez-Almoyna, et al.Neurology|July 29, 2016
Seizures in dominantly inherited Alzheimer diseaseAline Zarea, Camille Charbonnier, Anne Rovelet-Lecrux, et al.European Journal of Human Genetics : EJHG|April 2, 2015
Mutation in the 3'untranslated region of APP as a genetic determinant of cerebral amyloid angiopathyGaël Nicolas, David Wallon, Claudia Goupil, et al.Acta Neuropathologica|June 7, 2021
Clinical and neuropathological diversity of tauopathy in MAPT duplication carriersDavid Wallon, Susana Boluda, Anne Rovelet-Lecrux, et al.Brain : a Journal of Neurology|April 23, 2019
Biallelic MYORG mutation carriers exhibit primary brain calcification with a distinct phenotypeLou Grangeon, David Wallon, Camille Charbonnier, et al.Journal of Alzheimer'S Disease : JAD|April 6, 2012
The French series of autosomal dominant early onset Alzheimer's disease cases: mutation spectrum and cerebrospinal fluid biomarkersDavid Wallon, Stéphane Rousseau, Anne Rovelet-Lecrux, et al.Pageof 6